Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Surfactant protein D facilitates Cryptococcus neoformans infection.

Geunes-Boyer S, Beers MF, Perfect JR, Heitman J, Wright JR.

Infect Immun. 2012 Jul;80(7):2444-53. doi: 10.1128/IAI.05613-11. Epub 2012 Apr 30.

2.

Surfactant protein D increases phagocytosis of hypocapsular Cryptococcus neoformans by murine macrophages and enhances fungal survival.

Geunes-Boyer S, Oliver TN, Janbon G, Lodge JK, Heitman J, Perfect JR, Wright JR.

Infect Immun. 2009 Jul;77(7):2783-94. doi: 10.1128/IAI.00088-09. Epub 2009 May 18.

3.

Impact of surfactant protein D, interleukin-5, and eosinophilia on Cryptococcosis.

Holmer SM, Evans KS, Asfaw YG, Saini D, Schell WA, Ledford JG, Frothingham R, Wright JR, Sempowski GD, Perfect JR.

Infect Immun. 2014 Feb;82(2):683-93. doi: 10.1128/IAI.00855-13. Epub 2013 Nov 25.

4.

Role of host sphingosine kinase 1 in the lung response against Cryptococcosis.

McQuiston T, Luberto C, Del Poeta M.

Infect Immun. 2010 May;78(5):2342-52. doi: 10.1128/IAI.01140-09. Epub 2010 Mar 1.

5.

Cryptococcus neoformans-induced macrophage lysosome damage crucially contributes to fungal virulence.

Davis MJ, Eastman AJ, Qiu Y, Gregorka B, Kozel TR, Osterholzer JJ, Curtis JL, Swanson JA, Olszewski MA.

J Immunol. 2015 Mar 1;194(5):2219-31. doi: 10.4049/jimmunol.1402376. Epub 2015 Jan 30.

6.

Cryptococcus neoformans is resistant to surfactant protein A mediated host defense mechanisms.

Giles SS, Zaas AK, Reidy MF, Perfect JR, Wright JR.

PLoS One. 2007 Dec 26;2(12):e1370.

7.

Dectin-2 deficiency promotes Th2 response and mucin production in the lungs after pulmonary infection with Cryptococcus neoformans.

Nakamura Y, Sato K, Yamamoto H, Matsumura K, Matsumoto I, Nomura T, Miyasaka T, Ishii K, Kanno E, Tachi M, Yamasaki S, Saijo S, Iwakura Y, Kawakami K.

Infect Immun. 2015 Feb;83(2):671-81. doi: 10.1128/IAI.02835-14. Epub 2014 Nov 24.

8.
9.

STAT1 signaling within macrophages is required for antifungal activity against Cryptococcus neoformans.

Leopold Wager CM, Hole CR, Wozniak KL, Olszewski MA, Mueller M, Wormley FL Jr.

Infect Immun. 2015 Dec;83(12):4513-27. doi: 10.1128/IAI.00935-15. Epub 2015 Sep 8.

10.

The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans.

Subramaniam KS, Datta K, Quintero E, Manix C, Marks MS, Pirofski LA.

J Immunol. 2010 May 15;184(10):5755-67. doi: 10.4049/jimmunol.0901638. Epub 2010 Apr 19.

11.

X-linked immunodeficient mice exhibit enhanced susceptibility to Cryptococcus neoformans Infection.

Szymczak WA, Davis MJ, Lundy SK, Dufaud C, Olszewski M, Pirofski LA.

MBio. 2013 Jul 2;4(4). pii: e00265-13. doi: 10.1128/mBio.00265-13.

12.

Aggregation of Cryptococcus neoformans by surfactant protein D is inhibited by its capsular component glucuronoxylomannan.

van de Wetering JK, Coenjaerts FE, Vaandrager AB, van Golde LM, Batenburg JJ.

Infect Immun. 2004 Jan;72(1):145-53.

13.

Dynamic virulence: real-time assessment of intracellular pathogenesis links Cryptococcus neoformans phenotype with clinical outcome.

Mansour MK, Vyas JM, Levitz SM.

MBio. 2011 Sep 27;2(5). pii: e00217-11. doi: 10.1128/mBio.00217-11. Print 2011.

14.

Live Imaging of Host-Parasite Interactions in a Zebrafish Infection Model Reveals Cryptococcal Determinants of Virulence and Central Nervous System Invasion.

Tenor JL, Oehlers SH, Yang JL, Tobin DM, Perfect JR.

MBio. 2015 Sep 29;6(5):e01425-15. doi: 10.1128/mBio.01425-15.

15.

Cryptococcus neoformans Rim101 is associated with cell wall remodeling and evasion of the host immune responses.

O'Meara TR, Holmer SM, Selvig K, Dietrich F, Alspaugh JA.

MBio. 2013 Jan 15;4(1). pii: e00522-12. doi: 10.1128/mBio.00522-12.

16.
17.
18.
19.

Contribution of the myeloperoxidase-dependent oxidative system to host defence against Cryptococcus neoformans.

Aratani Y, Kura F, Watanabe H, Akagawa H, Takano Y, Ishida-Okawara A, Suzuki K, Maeda N, Koyama H.

J Med Microbiol. 2006 Sep;55(Pt 9):1291-9.

PMID:
16914663
20.

Mechanisms of cryptococcal virulence and persistence.

Olszewski MA, Zhang Y, Huffnagle GB.

Future Microbiol. 2010 Aug;5(8):1269-88. doi: 10.2217/fmb.10.93. Review.

PMID:
20722603

Supplemental Content

Support Center